nodes	percent_of_prediction	percent_of_DWPC	metapath
Betamethasone—PTGS2—kidney cancer	0.186	0.54	CbGaD
Betamethasone—ABCB1—kidney cancer	0.158	0.459	CbGaD
Betamethasone—CYP19A1—Paclitaxel—kidney cancer	0.0638	0.179	CbGbCtD
Betamethasone—ABCB1—Temsirolimus—kidney cancer	0.0393	0.11	CbGbCtD
Betamethasone—CYP3A4—Everolimus—kidney cancer	0.0349	0.0976	CbGbCtD
Betamethasone—CYP3A4—Temsirolimus—kidney cancer	0.0236	0.0659	CbGbCtD
Betamethasone—ABCB1—Pazopanib—kidney cancer	0.0207	0.0578	CbGbCtD
Betamethasone—ABCB1—Dactinomycin—kidney cancer	0.0189	0.0529	CbGbCtD
Betamethasone—ABCB1—Gemcitabine—kidney cancer	0.0149	0.0418	CbGbCtD
Betamethasone—ABCB1—Erlotinib—kidney cancer	0.0147	0.0412	CbGbCtD
Betamethasone—NR3C2—collecting duct of renal tubule—kidney cancer	0.0147	0.234	CbGeAlD
Betamethasone—ABCB1—Paclitaxel—kidney cancer	0.0135	0.0377	CbGbCtD
Betamethasone—PLA2G1B—nephron—kidney cancer	0.0132	0.21	CbGeAlD
Betamethasone—CYP3A4—Pazopanib—kidney cancer	0.0124	0.0346	CbGbCtD
Betamethasone—ABCB1—Sorafenib—kidney cancer	0.012	0.0335	CbGbCtD
Betamethasone—ABCB1—Vinblastine—kidney cancer	0.0118	0.0331	CbGbCtD
Betamethasone—ABCB1—Vincristine—kidney cancer	0.0116	0.0325	CbGbCtD
Betamethasone—ABCB1—Sunitinib—kidney cancer	0.00971	0.0272	CbGbCtD
Betamethasone—CYP3A4—Erlotinib—kidney cancer	0.00883	0.0247	CbGbCtD
Betamethasone—CYP3A4—Paclitaxel—kidney cancer	0.00808	0.0226	CbGbCtD
Betamethasone—ABCB1—Doxorubicin—kidney cancer	0.00727	0.0203	CbGbCtD
Betamethasone—CYP3A4—Sorafenib—kidney cancer	0.00718	0.0201	CbGbCtD
Betamethasone—CYP3A4—Vinblastine—kidney cancer	0.00709	0.0198	CbGbCtD
Betamethasone—CYP3A4—Vincristine—kidney cancer	0.00697	0.0195	CbGbCtD
Betamethasone—NR3C2—nephron—kidney cancer	0.00654	0.104	CbGeAlD
Betamethasone—CYP3A4—Sunitinib—kidney cancer	0.00582	0.0163	CbGbCtD
Betamethasone—CYP3A4—Doxorubicin—kidney cancer	0.00436	0.0122	CbGbCtD
Betamethasone—PTGS2—nephron—kidney cancer	0.00304	0.0484	CbGeAlD
Betamethasone—NR3C1—urine—kidney cancer	0.00281	0.0448	CbGeAlD
Betamethasone—PLA2G1B—renal system—kidney cancer	0.00259	0.0413	CbGeAlD
Betamethasone—PLA2G1B—kidney—kidney cancer	0.0025	0.0399	CbGeAlD
Betamethasone—CYP3A4—urine—kidney cancer	0.00213	0.0339	CbGeAlD
Betamethasone—NR3C2—nephron tubule—kidney cancer	0.00141	0.0225	CbGeAlD
Betamethasone—NR3C2—renal system—kidney cancer	0.00128	0.0204	CbGeAlD
Betamethasone—NR3C2—kidney—kidney cancer	0.00124	0.0198	CbGeAlD
Betamethasone—NR3C2—cortex of kidney—kidney cancer	0.00121	0.0193	CbGeAlD
Betamethasone—Amcinonide—ANXA1—kidney cancer	0.00118	0.367	CrCbGaD
Betamethasone—NR3C2—cardiac atrium—kidney cancer	0.00115	0.0183	CbGeAlD
Betamethasone—CYP19A1—gonad—kidney cancer	0.000963	0.0153	CbGeAlD
Betamethasone—NR3C1—nephron tubule—kidney cancer	0.000757	0.0121	CbGeAlD
Betamethasone—NR3C1—renal system—kidney cancer	0.000688	0.011	CbGeAlD
Betamethasone—NR3C1—kidney—kidney cancer	0.000665	0.0106	CbGeAlD
Betamethasone—NR3C1—cortex of kidney—kidney cancer	0.000648	0.0103	CbGeAlD
Betamethasone—NR3C1—gonad—kidney cancer	0.000617	0.00984	CbGeAlD
Betamethasone—NR3C1—cardiac atrium—kidney cancer	0.000616	0.00982	CbGeAlD
Betamethasone—PTGS2—renal system—kidney cancer	0.000596	0.00949	CbGeAlD
Betamethasone—PTGS2—kidney—kidney cancer	0.000576	0.00918	CbGeAlD
Betamethasone—CYP3A4—renal system—kidney cancer	0.00052	0.00829	CbGeAlD
Betamethasone—CYP3A4—kidney—kidney cancer	0.000503	0.00802	CbGeAlD
Betamethasone—Hydrocortisone—ANXA1—kidney cancer	0.000496	0.155	CrCbGaD
Betamethasone—ABCB1—nephron tubule—kidney cancer	0.000405	0.00646	CbGeAlD
Betamethasone—Dexamethasone—ANXA1—kidney cancer	0.000369	0.115	CrCbGaD
Betamethasone—ABCB1—renal system—kidney cancer	0.000368	0.00587	CbGeAlD
Betamethasone—ABCB1—kidney—kidney cancer	0.000356	0.00568	CbGeAlD
Betamethasone—ABCB1—cortex of kidney—kidney cancer	0.000347	0.00553	CbGeAlD
Betamethasone—ABCB1—gonad—kidney cancer	0.00033	0.00527	CbGeAlD
Betamethasone—Triamcinolone—BCHE—kidney cancer	0.000226	0.0706	CrCbGaD
Betamethasone—Clobetasol propionate—CYP1A1—kidney cancer	0.000212	0.0662	CrCbGaD
Betamethasone—Fluticasone furoate—ABCB1—kidney cancer	0.000132	0.0411	CrCbGaD
Betamethasone—Methylprednisolone—ABCB1—kidney cancer	0.000105	0.0328	CrCbGaD
Betamethasone—Triamcinolone—PTGS2—kidney cancer	0.000104	0.0325	CrCbGaD
Betamethasone—Cardiac failure congestive—Doxorubicin—kidney cancer	9.91e-05	0.000552	CcSEcCtD
Betamethasone—Infection—Gemcitabine—kidney cancer	9.91e-05	0.000552	CcSEcCtD
Betamethasone—Dizziness—Vinblastine—kidney cancer	9.88e-05	0.00055	CcSEcCtD
Betamethasone—Dizziness—Everolimus—kidney cancer	9.84e-05	0.000548	CcSEcCtD
Betamethasone—Body temperature increased—Sunitinib—kidney cancer	9.83e-05	0.000547	CcSEcCtD
Betamethasone—Abdominal pain—Sunitinib—kidney cancer	9.83e-05	0.000547	CcSEcCtD
Betamethasone—Diarrhoea—Erlotinib—kidney cancer	9.83e-05	0.000547	CcSEcCtD
Betamethasone—Hypotension—Vincristine—kidney cancer	9.83e-05	0.000547	CcSEcCtD
Betamethasone—Bradycardia—Capecitabine—kidney cancer	9.82e-05	0.000547	CcSEcCtD
Betamethasone—Nervous system disorder—Gemcitabine—kidney cancer	9.78e-05	0.000545	CcSEcCtD
Betamethasone—Thrombocytopenia—Gemcitabine—kidney cancer	9.77e-05	0.000544	CcSEcCtD
Betamethasone—Feeling abnormal—Dactinomycin—kidney cancer	9.7e-05	0.00054	CcSEcCtD
Betamethasone—Haemoglobin—Capecitabine—kidney cancer	9.7e-05	0.00054	CcSEcCtD
Betamethasone—Haemorrhage—Capecitabine—kidney cancer	9.65e-05	0.000537	CcSEcCtD
Betamethasone—Hyperhidrosis—Gemcitabine—kidney cancer	9.65e-05	0.000537	CcSEcCtD
Betamethasone—Gastrointestinal pain—Dactinomycin—kidney cancer	9.63e-05	0.000536	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Vincristine—kidney cancer	9.58e-05	0.000533	CcSEcCtD
Betamethasone—Increased appetite—Doxorubicin—kidney cancer	9.57e-05	0.000533	CcSEcCtD
Betamethasone—Insomnia—Vincristine—kidney cancer	9.51e-05	0.00053	CcSEcCtD
Betamethasone—Anorexia—Gemcitabine—kidney cancer	9.51e-05	0.000529	CcSEcCtD
Betamethasone—Vomiting—Vinblastine—kidney cancer	9.5e-05	0.000529	CcSEcCtD
Betamethasone—Dizziness—Erlotinib—kidney cancer	9.5e-05	0.000529	CcSEcCtD
Betamethasone—Ill-defined disorder—Paclitaxel—kidney cancer	9.5e-05	0.000529	CcSEcCtD
Betamethasone—Vomiting—Everolimus—kidney cancer	9.47e-05	0.000527	CcSEcCtD
Betamethasone—Paraesthesia—Vincristine—kidney cancer	9.44e-05	0.000526	CcSEcCtD
Betamethasone—Dermatitis bullous—Doxorubicin—kidney cancer	9.41e-05	0.000524	CcSEcCtD
Betamethasone—Rash—Everolimus—kidney cancer	9.39e-05	0.000523	CcSEcCtD
Betamethasone—Dermatitis—Everolimus—kidney cancer	9.38e-05	0.000522	CcSEcCtD
Betamethasone—Headache—Vinblastine—kidney cancer	9.36e-05	0.000521	CcSEcCtD
Betamethasone—Angioedema—Paclitaxel—kidney cancer	9.35e-05	0.000521	CcSEcCtD
Betamethasone—Headache—Everolimus—kidney cancer	9.33e-05	0.000519	CcSEcCtD
Betamethasone—Hypotension—Gemcitabine—kidney cancer	9.32e-05	0.000519	CcSEcCtD
Betamethasone—Abdominal pain—Dactinomycin—kidney cancer	9.31e-05	0.000518	CcSEcCtD
Betamethasone—Body temperature increased—Dactinomycin—kidney cancer	9.31e-05	0.000518	CcSEcCtD
Betamethasone—Visual impairment—Capecitabine—kidney cancer	9.3e-05	0.000518	CcSEcCtD
Betamethasone—Anaphylactoid reaction—Doxorubicin—kidney cancer	9.29e-05	0.000517	CcSEcCtD
Betamethasone—Asthenia—Sorafenib—kidney cancer	9.27e-05	0.000516	CcSEcCtD
Betamethasone—Malaise—Paclitaxel—kidney cancer	9.23e-05	0.000514	CcSEcCtD
Betamethasone—Cardiac failure—Doxorubicin—kidney cancer	9.21e-05	0.000513	CcSEcCtD
Betamethasone—Vertigo—Paclitaxel—kidney cancer	9.2e-05	0.000512	CcSEcCtD
Betamethasone—Syncope—Paclitaxel—kidney cancer	9.18e-05	0.000511	CcSEcCtD
Betamethasone—Lethargy—Doxorubicin—kidney cancer	9.17e-05	0.000511	CcSEcCtD
Betamethasone—Decreased appetite—Vincristine—kidney cancer	9.14e-05	0.000509	CcSEcCtD
Betamethasone—Pruritus—Sorafenib—kidney cancer	9.14e-05	0.000509	CcSEcCtD
Betamethasone—Vomiting—Erlotinib—kidney cancer	9.13e-05	0.000508	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Gemcitabine—kidney cancer	9.09e-05	0.000506	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Vincristine—kidney cancer	9.08e-05	0.000505	CcSEcCtD
Betamethasone—Fatigue—Vincristine—kidney cancer	9.07e-05	0.000505	CcSEcCtD
Betamethasone—Rash—Erlotinib—kidney cancer	9.06e-05	0.000504	CcSEcCtD
Betamethasone—Dermatitis—Erlotinib—kidney cancer	9.05e-05	0.000504	CcSEcCtD
Betamethasone—Insomnia—Gemcitabine—kidney cancer	9.02e-05	0.000502	CcSEcCtD
Betamethasone—Eye disorder—Capecitabine—kidney cancer	9.02e-05	0.000502	CcSEcCtD
Betamethasone—Headache—Erlotinib—kidney cancer	9e-05	0.000501	CcSEcCtD
Betamethasone—Loss of consciousness—Paclitaxel—kidney cancer	9e-05	0.000501	CcSEcCtD
Betamethasone—Pain—Vincristine—kidney cancer	8.99e-05	0.000501	CcSEcCtD
Betamethasone—Osteoarthritis—Doxorubicin—kidney cancer	8.99e-05	0.000501	CcSEcCtD
Betamethasone—Paraesthesia—Gemcitabine—kidney cancer	8.96e-05	0.000499	CcSEcCtD
Betamethasone—Asthenia—Sunitinib—kidney cancer	8.92e-05	0.000497	CcSEcCtD
Betamethasone—Nausea—Vinblastine—kidney cancer	8.88e-05	0.000494	CcSEcCtD
Betamethasone—Convulsion—Paclitaxel—kidney cancer	8.87e-05	0.000494	CcSEcCtD
Betamethasone—Migraine—Doxorubicin—kidney cancer	8.85e-05	0.000493	CcSEcCtD
Betamethasone—Affect lability—Doxorubicin—kidney cancer	8.85e-05	0.000493	CcSEcCtD
Betamethasone—Nausea—Everolimus—kidney cancer	8.84e-05	0.000492	CcSEcCtD
Betamethasone—Diarrhoea—Sorafenib—kidney cancer	8.84e-05	0.000492	CcSEcCtD
Betamethasone—Hypertension—Paclitaxel—kidney cancer	8.84e-05	0.000492	CcSEcCtD
Betamethasone—Pruritus—Sunitinib—kidney cancer	8.8e-05	0.00049	CcSEcCtD
Betamethasone—Angiopathy—Capecitabine—kidney cancer	8.75e-05	0.000487	CcSEcCtD
Betamethasone—Myalgia—Paclitaxel—kidney cancer	8.71e-05	0.000485	CcSEcCtD
Betamethasone—Anxiety—Paclitaxel—kidney cancer	8.68e-05	0.000483	CcSEcCtD
Betamethasone—Decreased appetite—Gemcitabine—kidney cancer	8.67e-05	0.000483	CcSEcCtD
Betamethasone—Arrhythmia—Capecitabine—kidney cancer	8.62e-05	0.00048	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Gemcitabine—kidney cancer	8.61e-05	0.00048	CcSEcCtD
Betamethasone—Discomfort—Paclitaxel—kidney cancer	8.61e-05	0.000479	CcSEcCtD
Betamethasone—Fatigue—Gemcitabine—kidney cancer	8.6e-05	0.000479	CcSEcCtD
Betamethasone—Gastrointestinal pain—Vincristine—kidney cancer	8.6e-05	0.000479	CcSEcCtD
Betamethasone—Cardiac arrest—Doxorubicin—kidney cancer	8.55e-05	0.000476	CcSEcCtD
Betamethasone—Dizziness—Sorafenib—kidney cancer	8.55e-05	0.000476	CcSEcCtD
Betamethasone—Pain—Gemcitabine—kidney cancer	8.53e-05	0.000475	CcSEcCtD
Betamethasone—Nausea—Erlotinib—kidney cancer	8.53e-05	0.000475	CcSEcCtD
Betamethasone—Alopecia—Capecitabine—kidney cancer	8.53e-05	0.000475	CcSEcCtD
Betamethasone—Mood swings—Doxorubicin—kidney cancer	8.52e-05	0.000474	CcSEcCtD
Betamethasone—Diarrhoea—Sunitinib—kidney cancer	8.51e-05	0.000474	CcSEcCtD
Betamethasone—Asthenia—Dactinomycin—kidney cancer	8.45e-05	0.00047	CcSEcCtD
Betamethasone—Erythema—Capecitabine—kidney cancer	8.4e-05	0.000468	CcSEcCtD
Betamethasone—Anaphylactic shock—Paclitaxel—kidney cancer	8.35e-05	0.000465	CcSEcCtD
Betamethasone—Oedema—Paclitaxel—kidney cancer	8.35e-05	0.000465	CcSEcCtD
Betamethasone—Abdominal pain—Vincristine—kidney cancer	8.31e-05	0.000463	CcSEcCtD
Betamethasone—Body temperature increased—Vincristine—kidney cancer	8.31e-05	0.000463	CcSEcCtD
Betamethasone—Infection—Paclitaxel—kidney cancer	8.3e-05	0.000462	CcSEcCtD
Betamethasone—Dry skin—Doxorubicin—kidney cancer	8.24e-05	0.000459	CcSEcCtD
Betamethasone—Dizziness—Sunitinib—kidney cancer	8.22e-05	0.000458	CcSEcCtD
Betamethasone—Feeling abnormal—Gemcitabine—kidney cancer	8.22e-05	0.000458	CcSEcCtD
Betamethasone—Shock—Paclitaxel—kidney cancer	8.22e-05	0.000458	CcSEcCtD
Betamethasone—Vomiting—Sorafenib—kidney cancer	8.22e-05	0.000457	CcSEcCtD
Betamethasone—Nervous system disorder—Paclitaxel—kidney cancer	8.19e-05	0.000456	CcSEcCtD
Betamethasone—Hypokalaemia—Doxorubicin—kidney cancer	8.18e-05	0.000456	CcSEcCtD
Betamethasone—Thrombocytopenia—Paclitaxel—kidney cancer	8.18e-05	0.000455	CcSEcCtD
Betamethasone—Tachycardia—Paclitaxel—kidney cancer	8.15e-05	0.000454	CcSEcCtD
Betamethasone—Rash—Sorafenib—kidney cancer	8.15e-05	0.000454	CcSEcCtD
Betamethasone—Dermatitis—Sorafenib—kidney cancer	8.14e-05	0.000453	CcSEcCtD
Betamethasone—Headache—Sorafenib—kidney cancer	8.1e-05	0.000451	CcSEcCtD
Betamethasone—Hyperhidrosis—Paclitaxel—kidney cancer	8.08e-05	0.00045	CcSEcCtD
Betamethasone—Diarrhoea—Dactinomycin—kidney cancer	8.05e-05	0.000448	CcSEcCtD
Betamethasone—Prednisone—ABCB1—kidney cancer	8.03e-05	0.0251	CrCbGaD
Betamethasone—Anorexia—Paclitaxel—kidney cancer	7.96e-05	0.000443	CcSEcCtD
Betamethasone—Dexamethasone—CYP1A1—kidney cancer	7.94e-05	0.0248	CrCbGaD
Betamethasone—Muscular weakness—Doxorubicin—kidney cancer	7.93e-05	0.000441	CcSEcCtD
Betamethasone—Vomiting—Sunitinib—kidney cancer	7.91e-05	0.00044	CcSEcCtD
Betamethasone—Body temperature increased—Gemcitabine—kidney cancer	7.89e-05	0.000439	CcSEcCtD
Betamethasone—Rash—Sunitinib—kidney cancer	7.84e-05	0.000436	CcSEcCtD
Betamethasone—Dermatitis—Sunitinib—kidney cancer	7.83e-05	0.000436	CcSEcCtD
Betamethasone—Hypotension—Paclitaxel—kidney cancer	7.81e-05	0.000435	CcSEcCtD
Betamethasone—Ill-defined disorder—Capecitabine—kidney cancer	7.79e-05	0.000434	CcSEcCtD
Betamethasone—Headache—Sunitinib—kidney cancer	7.79e-05	0.000434	CcSEcCtD
Betamethasone—Nausea—Sorafenib—kidney cancer	7.68e-05	0.000427	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	7.61e-05	0.000424	CcSEcCtD
Betamethasone—Malaise—Capecitabine—kidney cancer	7.57e-05	0.000422	CcSEcCtD
Betamethasone—Insomnia—Paclitaxel—kidney cancer	7.56e-05	0.000421	CcSEcCtD
Betamethasone—Vertigo—Capecitabine—kidney cancer	7.55e-05	0.00042	CcSEcCtD
Betamethasone—Asthenia—Vincristine—kidney cancer	7.55e-05	0.00042	CcSEcCtD
Betamethasone—Syncope—Capecitabine—kidney cancer	7.53e-05	0.000419	CcSEcCtD
Betamethasone—Paraesthesia—Paclitaxel—kidney cancer	7.5e-05	0.000418	CcSEcCtD
Betamethasone—Vomiting—Dactinomycin—kidney cancer	7.48e-05	0.000417	CcSEcCtD
Betamethasone—Rash—Dactinomycin—kidney cancer	7.42e-05	0.000413	CcSEcCtD
Betamethasone—Prednisolone—ABCB1—kidney cancer	7.4e-05	0.0231	CrCbGaD
Betamethasone—Nausea—Sunitinib—kidney cancer	7.39e-05	0.000411	CcSEcCtD
Betamethasone—Loss of consciousness—Capecitabine—kidney cancer	7.38e-05	0.000411	CcSEcCtD
Betamethasone—Dyspepsia—Paclitaxel—kidney cancer	7.35e-05	0.000409	CcSEcCtD
Betamethasone—Decreased appetite—Paclitaxel—kidney cancer	7.26e-05	0.000404	CcSEcCtD
Betamethasone—Hypertension—Capecitabine—kidney cancer	7.25e-05	0.000404	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Paclitaxel—kidney cancer	7.21e-05	0.000401	CcSEcCtD
Betamethasone—Fatigue—Paclitaxel—kidney cancer	7.2e-05	0.000401	CcSEcCtD
Betamethasone—Diarrhoea—Vincristine—kidney cancer	7.2e-05	0.000401	CcSEcCtD
Betamethasone—Asthenia—Gemcitabine—kidney cancer	7.16e-05	0.000399	CcSEcCtD
Betamethasone—Myalgia—Capecitabine—kidney cancer	7.15e-05	0.000398	CcSEcCtD
Betamethasone—Pain—Paclitaxel—kidney cancer	7.14e-05	0.000398	CcSEcCtD
Betamethasone—Anxiety—Capecitabine—kidney cancer	7.13e-05	0.000397	CcSEcCtD
Betamethasone—Weight increased—Doxorubicin—kidney cancer	7.07e-05	0.000394	CcSEcCtD
Betamethasone—Discomfort—Capecitabine—kidney cancer	7.07e-05	0.000393	CcSEcCtD
Betamethasone—Pruritus—Gemcitabine—kidney cancer	7.06e-05	0.000393	CcSEcCtD
Betamethasone—Weight decreased—Doxorubicin—kidney cancer	7.03e-05	0.000391	CcSEcCtD
Betamethasone—Hyperglycaemia—Doxorubicin—kidney cancer	7.01e-05	0.00039	CcSEcCtD
Betamethasone—Nausea—Dactinomycin—kidney cancer	6.99e-05	0.000389	CcSEcCtD
Betamethasone—Dizziness—Vincristine—kidney cancer	6.95e-05	0.000387	CcSEcCtD
Betamethasone—Feeling abnormal—Paclitaxel—kidney cancer	6.88e-05	0.000383	CcSEcCtD
Betamethasone—Oedema—Capecitabine—kidney cancer	6.86e-05	0.000382	CcSEcCtD
Betamethasone—Gastrointestinal pain—Paclitaxel—kidney cancer	6.83e-05	0.00038	CcSEcCtD
Betamethasone—Diarrhoea—Gemcitabine—kidney cancer	6.83e-05	0.00038	CcSEcCtD
Betamethasone—Infection—Capecitabine—kidney cancer	6.81e-05	0.000379	CcSEcCtD
Betamethasone—Neuropathy peripheral—Doxorubicin—kidney cancer	6.79e-05	0.000378	CcSEcCtD
Betamethasone—Shock—Capecitabine—kidney cancer	6.74e-05	0.000375	CcSEcCtD
Betamethasone—Conjunctivitis—Doxorubicin—kidney cancer	6.73e-05	0.000375	CcSEcCtD
Betamethasone—Nervous system disorder—Capecitabine—kidney cancer	6.72e-05	0.000374	CcSEcCtD
Betamethasone—Thrombocytopenia—Capecitabine—kidney cancer	6.71e-05	0.000374	CcSEcCtD
Betamethasone—Tachycardia—Capecitabine—kidney cancer	6.69e-05	0.000372	CcSEcCtD
Betamethasone—Vomiting—Vincristine—kidney cancer	6.69e-05	0.000372	CcSEcCtD
Betamethasone—Urticaria—Paclitaxel—kidney cancer	6.64e-05	0.000369	CcSEcCtD
Betamethasone—Rash—Vincristine—kidney cancer	6.63e-05	0.000369	CcSEcCtD
Betamethasone—Hyperhidrosis—Capecitabine—kidney cancer	6.63e-05	0.000369	CcSEcCtD
Betamethasone—Dermatitis—Vincristine—kidney cancer	6.63e-05	0.000369	CcSEcCtD
Betamethasone—Body temperature increased—Paclitaxel—kidney cancer	6.6e-05	0.000368	CcSEcCtD
Betamethasone—Abdominal pain—Paclitaxel—kidney cancer	6.6e-05	0.000368	CcSEcCtD
Betamethasone—Headache—Vincristine—kidney cancer	6.59e-05	0.000367	CcSEcCtD
Betamethasone—Anorexia—Capecitabine—kidney cancer	6.53e-05	0.000364	CcSEcCtD
Betamethasone—Hypotension—Capecitabine—kidney cancer	6.41e-05	0.000357	CcSEcCtD
Betamethasone—Vomiting—Gemcitabine—kidney cancer	6.34e-05	0.000353	CcSEcCtD
Betamethasone—Bradycardia—Doxorubicin—kidney cancer	6.33e-05	0.000352	CcSEcCtD
Betamethasone—Rash—Gemcitabine—kidney cancer	6.29e-05	0.00035	CcSEcCtD
Betamethasone—Dermatitis—Gemcitabine—kidney cancer	6.29e-05	0.00035	CcSEcCtD
Betamethasone—Haemoglobin—Doxorubicin—kidney cancer	6.25e-05	0.000348	CcSEcCtD
Betamethasone—Headache—Gemcitabine—kidney cancer	6.25e-05	0.000348	CcSEcCtD
Betamethasone—Nausea—Vincristine—kidney cancer	6.25e-05	0.000348	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Capecitabine—kidney cancer	6.25e-05	0.000348	CcSEcCtD
Betamethasone—Haemorrhage—Doxorubicin—kidney cancer	6.22e-05	0.000346	CcSEcCtD
Betamethasone—Insomnia—Capecitabine—kidney cancer	6.2e-05	0.000345	CcSEcCtD
Betamethasone—Paraesthesia—Capecitabine—kidney cancer	6.16e-05	0.000343	CcSEcCtD
Betamethasone—Dyspepsia—Capecitabine—kidney cancer	6.03e-05	0.000336	CcSEcCtD
Betamethasone—Visual impairment—Doxorubicin—kidney cancer	5.99e-05	0.000334	CcSEcCtD
Betamethasone—Asthenia—Paclitaxel—kidney cancer	5.99e-05	0.000334	CcSEcCtD
Betamethasone—Decreased appetite—Capecitabine—kidney cancer	5.96e-05	0.000332	CcSEcCtD
Betamethasone—Nausea—Gemcitabine—kidney cancer	5.93e-05	0.00033	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Capecitabine—kidney cancer	5.92e-05	0.000329	CcSEcCtD
Betamethasone—Fatigue—Capecitabine—kidney cancer	5.91e-05	0.000329	CcSEcCtD
Betamethasone—Pruritus—Paclitaxel—kidney cancer	5.91e-05	0.000329	CcSEcCtD
Betamethasone—Pain—Capecitabine—kidney cancer	5.86e-05	0.000326	CcSEcCtD
Betamethasone—Eye disorder—Doxorubicin—kidney cancer	5.81e-05	0.000324	CcSEcCtD
Betamethasone—Diarrhoea—Paclitaxel—kidney cancer	5.72e-05	0.000318	CcSEcCtD
Betamethasone—Hydrocortisone—ABCB1—kidney cancer	5.66e-05	0.0177	CrCbGaD
Betamethasone—Feeling abnormal—Capecitabine—kidney cancer	5.65e-05	0.000314	CcSEcCtD
Betamethasone—Angiopathy—Doxorubicin—kidney cancer	5.64e-05	0.000314	CcSEcCtD
Betamethasone—Gastrointestinal pain—Capecitabine—kidney cancer	5.61e-05	0.000312	CcSEcCtD
Betamethasone—Arrhythmia—Doxorubicin—kidney cancer	5.56e-05	0.000309	CcSEcCtD
Betamethasone—Dizziness—Paclitaxel—kidney cancer	5.52e-05	0.000308	CcSEcCtD
Betamethasone—Alopecia—Doxorubicin—kidney cancer	5.5e-05	0.000306	CcSEcCtD
Betamethasone—Urticaria—Capecitabine—kidney cancer	5.45e-05	0.000303	CcSEcCtD
Betamethasone—Abdominal pain—Capecitabine—kidney cancer	5.42e-05	0.000302	CcSEcCtD
Betamethasone—Body temperature increased—Capecitabine—kidney cancer	5.42e-05	0.000302	CcSEcCtD
Betamethasone—Erythema—Doxorubicin—kidney cancer	5.41e-05	0.000301	CcSEcCtD
Betamethasone—Vomiting—Paclitaxel—kidney cancer	5.31e-05	0.000296	CcSEcCtD
Betamethasone—Rash—Paclitaxel—kidney cancer	5.27e-05	0.000293	CcSEcCtD
Betamethasone—Dermatitis—Paclitaxel—kidney cancer	5.26e-05	0.000293	CcSEcCtD
Betamethasone—Headache—Paclitaxel—kidney cancer	5.23e-05	0.000291	CcSEcCtD
Betamethasone—Ill-defined disorder—Doxorubicin—kidney cancer	5.02e-05	0.00028	CcSEcCtD
Betamethasone—Nausea—Paclitaxel—kidney cancer	4.96e-05	0.000276	CcSEcCtD
Betamethasone—Dexamethasone—PTGS2—kidney cancer	4.96e-05	0.0155	CrCbGaD
Betamethasone—Asthenia—Capecitabine—kidney cancer	4.92e-05	0.000274	CcSEcCtD
Betamethasone—Malaise—Doxorubicin—kidney cancer	4.88e-05	0.000272	CcSEcCtD
Betamethasone—Vertigo—Doxorubicin—kidney cancer	4.86e-05	0.000271	CcSEcCtD
Betamethasone—Syncope—Doxorubicin—kidney cancer	4.86e-05	0.00027	CcSEcCtD
Betamethasone—Pruritus—Capecitabine—kidney cancer	4.85e-05	0.00027	CcSEcCtD
Betamethasone—Loss of consciousness—Doxorubicin—kidney cancer	4.76e-05	0.000265	CcSEcCtD
Betamethasone—Convulsion—Doxorubicin—kidney cancer	4.69e-05	0.000261	CcSEcCtD
Betamethasone—Diarrhoea—Capecitabine—kidney cancer	4.69e-05	0.000261	CcSEcCtD
Betamethasone—Hypertension—Doxorubicin—kidney cancer	4.67e-05	0.00026	CcSEcCtD
Betamethasone—Myalgia—Doxorubicin—kidney cancer	4.61e-05	0.000257	CcSEcCtD
Betamethasone—Anxiety—Doxorubicin—kidney cancer	4.59e-05	0.000256	CcSEcCtD
Betamethasone—Discomfort—Doxorubicin—kidney cancer	4.55e-05	0.000254	CcSEcCtD
Betamethasone—Dizziness—Capecitabine—kidney cancer	4.53e-05	0.000252	CcSEcCtD
Betamethasone—Anaphylactic shock—Doxorubicin—kidney cancer	4.42e-05	0.000246	CcSEcCtD
Betamethasone—Oedema—Doxorubicin—kidney cancer	4.42e-05	0.000246	CcSEcCtD
Betamethasone—Infection—Doxorubicin—kidney cancer	4.39e-05	0.000244	CcSEcCtD
Betamethasone—Vomiting—Capecitabine—kidney cancer	4.36e-05	0.000243	CcSEcCtD
Betamethasone—Shock—Doxorubicin—kidney cancer	4.35e-05	0.000242	CcSEcCtD
Betamethasone—Nervous system disorder—Doxorubicin—kidney cancer	4.33e-05	0.000241	CcSEcCtD
Betamethasone—Thrombocytopenia—Doxorubicin—kidney cancer	4.33e-05	0.000241	CcSEcCtD
Betamethasone—Rash—Capecitabine—kidney cancer	4.32e-05	0.000241	CcSEcCtD
Betamethasone—Dermatitis—Capecitabine—kidney cancer	4.32e-05	0.00024	CcSEcCtD
Betamethasone—Tachycardia—Doxorubicin—kidney cancer	4.31e-05	0.00024	CcSEcCtD
Betamethasone—Headache—Capecitabine—kidney cancer	4.29e-05	0.000239	CcSEcCtD
Betamethasone—Hyperhidrosis—Doxorubicin—kidney cancer	4.27e-05	0.000238	CcSEcCtD
Betamethasone—Dexamethasone—ABCB1—kidney cancer	4.22e-05	0.0132	CrCbGaD
Betamethasone—Anorexia—Doxorubicin—kidney cancer	4.21e-05	0.000234	CcSEcCtD
Betamethasone—Hypotension—Doxorubicin—kidney cancer	4.13e-05	0.00023	CcSEcCtD
Betamethasone—Nausea—Capecitabine—kidney cancer	4.07e-05	0.000227	CcSEcCtD
Betamethasone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	4.03e-05	0.000224	CcSEcCtD
Betamethasone—Insomnia—Doxorubicin—kidney cancer	4e-05	0.000222	CcSEcCtD
Betamethasone—Paraesthesia—Doxorubicin—kidney cancer	3.97e-05	0.000221	CcSEcCtD
Betamethasone—Dyspepsia—Doxorubicin—kidney cancer	3.89e-05	0.000217	CcSEcCtD
Betamethasone—Decreased appetite—Doxorubicin—kidney cancer	3.84e-05	0.000214	CcSEcCtD
Betamethasone—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.82e-05	0.000212	CcSEcCtD
Betamethasone—Fatigue—Doxorubicin—kidney cancer	3.81e-05	0.000212	CcSEcCtD
Betamethasone—Pain—Doxorubicin—kidney cancer	3.78e-05	0.00021	CcSEcCtD
Betamethasone—Feeling abnormal—Doxorubicin—kidney cancer	3.64e-05	0.000203	CcSEcCtD
Betamethasone—Gastrointestinal pain—Doxorubicin—kidney cancer	3.61e-05	0.000201	CcSEcCtD
Betamethasone—Urticaria—Doxorubicin—kidney cancer	3.51e-05	0.000195	CcSEcCtD
Betamethasone—Abdominal pain—Doxorubicin—kidney cancer	3.49e-05	0.000194	CcSEcCtD
Betamethasone—Body temperature increased—Doxorubicin—kidney cancer	3.49e-05	0.000194	CcSEcCtD
Betamethasone—Asthenia—Doxorubicin—kidney cancer	3.17e-05	0.000176	CcSEcCtD
Betamethasone—Pruritus—Doxorubicin—kidney cancer	3.13e-05	0.000174	CcSEcCtD
Betamethasone—Diarrhoea—Doxorubicin—kidney cancer	3.02e-05	0.000168	CcSEcCtD
Betamethasone—Dizziness—Doxorubicin—kidney cancer	2.92e-05	0.000163	CcSEcCtD
Betamethasone—Vomiting—Doxorubicin—kidney cancer	2.81e-05	0.000156	CcSEcCtD
Betamethasone—Rash—Doxorubicin—kidney cancer	2.79e-05	0.000155	CcSEcCtD
Betamethasone—Dermatitis—Doxorubicin—kidney cancer	2.78e-05	0.000155	CcSEcCtD
Betamethasone—Headache—Doxorubicin—kidney cancer	2.77e-05	0.000154	CcSEcCtD
Betamethasone—Nausea—Doxorubicin—kidney cancer	2.62e-05	0.000146	CcSEcCtD
Betamethasone—NR3C1—Gene Expression—RPL14—kidney cancer	2.61e-05	0.000497	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MYC—kidney cancer	2.61e-05	0.000497	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.58e-05	0.000491	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.57e-05	0.00049	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—MAPK1—kidney cancer	2.55e-05	0.000486	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—FH—kidney cancer	2.54e-05	0.000483	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—APRT—kidney cancer	2.54e-05	0.000483	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.53e-05	0.000482	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.5e-05	0.000477	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—CDKN2B—kidney cancer	2.5e-05	0.000476	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.48e-05	0.000472	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PGK1—kidney cancer	2.47e-05	0.00047	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SLC5A3—kidney cancer	2.47e-05	0.00047	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SFRP2—kidney cancer	2.42e-05	0.000461	CbGpPWpGaD
Betamethasone—PTGS2—Disease—LDHB—kidney cancer	2.42e-05	0.000461	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CTNNA1—kidney cancer	2.41e-05	0.000458	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HSPB1—kidney cancer	2.39e-05	0.000456	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—EIF4EBP1—kidney cancer	2.39e-05	0.000456	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GPC3—kidney cancer	2.39e-05	0.000454	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PDHB—kidney cancer	2.37e-05	0.000452	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—POMC—kidney cancer	2.34e-05	0.000445	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CA2—kidney cancer	2.32e-05	0.000442	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.32e-05	0.000442	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	2.29e-05	0.000435	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ALAD—kidney cancer	2.26e-05	0.000431	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TCEB1—kidney cancer	2.26e-05	0.00043	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TCEB2—kidney cancer	2.26e-05	0.00043	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.25e-05	0.000427	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CRABP1—kidney cancer	2.24e-05	0.000426	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CCBL1—kidney cancer	2.23e-05	0.000425	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PSMD7—kidney cancer	2.22e-05	0.000423	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TSC1—kidney cancer	2.22e-05	0.000423	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ANXA1—kidney cancer	2.22e-05	0.000423	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.21e-05	0.000421	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.21e-05	0.000421	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ST3GAL2—kidney cancer	2.21e-05	0.00042	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.21e-05	0.00042	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.19e-05	0.000417	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ALDH1A1—kidney cancer	2.16e-05	0.000411	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—FLT1—kidney cancer	2.15e-05	0.00041	CbGpPWpGaD
Betamethasone—PTGS2—Spinal Cord Injury—TP53—kidney cancer	2.14e-05	0.000408	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.14e-05	0.000407	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—HSPB1—kidney cancer	2.13e-05	0.000405	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—EIF4EBP1—kidney cancer	2.13e-05	0.000405	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ITPR2—kidney cancer	2.08e-05	0.000396	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PGK1—kidney cancer	2.07e-05	0.000394	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SLC5A3—kidney cancer	2.07e-05	0.000394	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.06e-05	0.000393	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.04e-05	0.000387	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—LDHB—kidney cancer	2.03e-05	0.000386	CbGpPWpGaD
Betamethasone—PGR—Generic Transcription Pathway—MYC—kidney cancer	2.01e-05	0.000383	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—JUNB—kidney cancer	2e-05	0.00038	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PAK1—kidney cancer	2e-05	0.00038	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—PSMD7—kidney cancer	1.98e-05	0.000376	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.96e-05	0.000372	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GLIPR1—kidney cancer	1.94e-05	0.000368	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PPAT—kidney cancer	1.94e-05	0.000368	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.93e-05	0.000367	CbGpPWpGaD
Betamethasone—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.93e-05	0.000367	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.92e-05	0.000365	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GSTT1—kidney cancer	1.9e-05	0.000361	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ACHE—kidney cancer	1.9e-05	0.000361	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTGS2—kidney cancer	1.87e-05	0.000355	CbGpPWpGaD
Betamethasone—PTGS2—Disease—RPL14—kidney cancer	1.84e-05	0.00035	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.83e-05	0.000347	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—FH—kidney cancer	1.8e-05	0.000343	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—APRT—kidney cancer	1.8e-05	0.000343	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SCARB1—kidney cancer	1.8e-05	0.000342	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	1.79e-05	0.000342	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS1—kidney cancer	1.78e-05	0.000339	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—JUNB—kidney cancer	1.78e-05	0.000338	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	1.78e-05	0.000338	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.78e-05	0.000338	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CA9—kidney cancer	1.76e-05	0.000335	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PSMD7—kidney cancer	1.74e-05	0.000332	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.74e-05	0.000331	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	1.74e-05	0.00033	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ACY1—kidney cancer	1.72e-05	0.000327	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.72e-05	0.000327	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GPC3—kidney cancer	1.69e-05	0.000322	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ITPR2—kidney cancer	1.66e-05	0.000316	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—BCHE—kidney cancer	1.65e-05	0.000315	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.65e-05	0.000314	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CA2—kidney cancer	1.65e-05	0.000313	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.64e-05	0.000313	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.64e-05	0.000312	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—MAPK3—kidney cancer	1.64e-05	0.000311	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SLC5A5—kidney cancer	1.63e-05	0.000311	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IGF2—kidney cancer	1.63e-05	0.000311	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PTEN—kidney cancer	1.63e-05	0.00031	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN2B—kidney cancer	1.63e-05	0.000309	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ALAD—kidney cancer	1.6e-05	0.000305	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.6e-05	0.000304	CbGpPWpGaD
Betamethasone—NR3C2—Gene Expression—MYC—kidney cancer	1.59e-05	0.000303	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IGF1R—kidney cancer	1.58e-05	0.000301	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—SLC2A1—kidney cancer	1.58e-05	0.0003	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.57e-05	0.000299	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.57e-05	0.000298	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.57e-05	0.000298	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.55e-05	0.000296	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.53e-05	0.000291	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.53e-05	0.000291	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.51e-05	0.000288	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.51e-05	0.000287	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CRABP1—kidney cancer	1.5e-05	0.000285	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PGK1—kidney cancer	1.47e-05	0.000279	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC5A3—kidney cancer	1.47e-05	0.000279	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PDHB—kidney cancer	1.46e-05	0.000278	CbGpPWpGaD
Betamethasone—CYP3A4—Biological oxidations—POMC—kidney cancer	1.46e-05	0.000278	CbGpPWpGaD
Betamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.46e-05	0.000277	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—CDKN2B—kidney cancer	1.45e-05	0.000275	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—LDHB—kidney cancer	1.44e-05	0.000274	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PSMD7—kidney cancer	1.39e-05	0.000265	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ITPR2—kidney cancer	1.39e-05	0.000265	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CCBL1—kidney cancer	1.38e-05	0.000262	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.37e-05	0.00026	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.33e-05	0.000254	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GSTP1—kidney cancer	1.32e-05	0.00025	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—HIF1A—kidney cancer	1.3e-05	0.000247	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TSC2—kidney cancer	1.3e-05	0.000247	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.29e-05	0.000246	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.28e-05	0.000244	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ACHE—kidney cancer	1.27e-05	0.000241	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTT1—kidney cancer	1.27e-05	0.000241	CbGpPWpGaD
Betamethasone—PTGS2—Disease—SLC2A1—kidney cancer	1.26e-05	0.00024	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.26e-05	0.00024	CbGpPWpGaD
Betamethasone—PTGS2—Disease—JUNB—kidney cancer	1.25e-05	0.000238	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CA9—kidney cancer	1.25e-05	0.000237	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—ABCB1—kidney cancer	1.25e-05	0.000237	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KDR—kidney cancer	1.24e-05	0.000237	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	1.23e-05	0.000234	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—GSTM1—kidney cancer	1.21e-05	0.00023	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SCARB1—kidney cancer	1.2e-05	0.000229	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.19e-05	0.000227	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PPAT—kidney cancer	1.19e-05	0.000227	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PTGS1—kidney cancer	1.19e-05	0.000226	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PSMD7—kidney cancer	1.17e-05	0.000222	CbGpPWpGaD
Betamethasone—NR3C1—Generic Transcription Pathway—MYC—kidney cancer	1.16e-05	0.000221	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.16e-05	0.000221	CbGpPWpGaD
Betamethasone—PLA2G1B—Metabolism—PIK3CA—kidney cancer	1.15e-05	0.000219	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—CYP1A1—kidney cancer	1.15e-05	0.000218	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KIT—kidney cancer	1.15e-05	0.000218	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—APC—kidney cancer	1.15e-05	0.000218	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—FH—kidney cancer	1.11e-05	0.000211	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—APRT—kidney cancer	1.11e-05	0.000211	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—BCHE—kidney cancer	1.11e-05	0.00021	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SLC5A5—kidney cancer	1.09e-05	0.000208	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—POMC—kidney cancer	1.09e-05	0.000207	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—BRAF—kidney cancer	1.08e-05	0.000205	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.07e-05	0.000203	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CRABP1—kidney cancer	1.06e-05	0.000202	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—SLC2A1—kidney cancer	1.05e-05	0.000201	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GPC3—kidney cancer	1.04e-05	0.000198	CbGpPWpGaD
Betamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.03e-05	0.000197	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN2B—kidney cancer	1.02e-05	0.000194	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CA2—kidney cancer	1.01e-05	0.000193	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MAPK3—kidney cancer	9.96e-06	0.00019	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ALAD—kidney cancer	9.88e-06	0.000188	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ITPR2—kidney cancer	9.86e-06	0.000188	CbGpPWpGaD
Betamethasone—PGR—Gene Expression—MYC—kidney cancer	9.69e-06	0.000184	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	9.65e-06	0.000184	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	9.43e-06	0.000179	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.42e-06	0.000179	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PGK1—kidney cancer	9.04e-06	0.000172	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC5A3—kidney cancer	9.04e-06	0.000172	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—ACHE—kidney cancer	8.99e-06	0.000171	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTT1—kidney cancer	8.99e-06	0.000171	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RAF1—kidney cancer	8.99e-06	0.000171	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—RELA—kidney cancer	8.95e-06	0.00017	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	8.92e-06	0.00017	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—ERBB2—kidney cancer	8.89e-06	0.000169	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—LDHB—kidney cancer	8.86e-06	0.000169	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTP1—kidney cancer	8.79e-06	0.000167	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MTOR—kidney cancer	8.77e-06	0.000167	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—POMC—kidney cancer	8.55e-06	0.000163	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SCARB1—kidney cancer	8.51e-06	0.000162	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS1—kidney cancer	8.43e-06	0.00016	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—ABCB1—kidney cancer	8.32e-06	0.000158	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PSMD7—kidney cancer	8.26e-06	0.000157	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CDKN1B—kidney cancer	8.23e-06	0.000157	CbGpPWpGaD
Betamethasone—PTGS2—Disease—HIF1A—kidney cancer	8.13e-06	0.000155	CbGpPWpGaD
Betamethasone—PTGS2—Disease—TSC2—kidney cancer	8.11e-06	0.000154	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—GSTM1—kidney cancer	8.08e-06	0.000154	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—IL2—kidney cancer	8.06e-06	0.000153	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CCND1—kidney cancer	7.86e-06	0.00015	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—JUN—kidney cancer	7.84e-06	0.000149	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—BCHE—kidney cancer	7.83e-06	0.000149	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—CTNNB1—kidney cancer	7.78e-06	0.000148	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC5A5—kidney cancer	7.74e-06	0.000147	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CA9—kidney cancer	7.69e-06	0.000146	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—CYP1A1—kidney cancer	7.66e-06	0.000146	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PTEN—kidney cancer	7.58e-06	0.000144	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—SLC2A1—kidney cancer	7.47e-06	0.000142	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KIT—kidney cancer	7.16e-06	0.000136	CbGpPWpGaD
Betamethasone—PTGS2—Disease—APC—kidney cancer	7.16e-06	0.000136	CbGpPWpGaD
Betamethasone—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	7.13e-06	0.000136	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—VEGFA—kidney cancer	6.85e-06	0.00013	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTGS2—kidney cancer	6.82e-06	0.00013	CbGpPWpGaD
Betamethasone—PTGS2—Disease—BRAF—kidney cancer	6.73e-06	0.000128	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CRABP1—kidney cancer	6.53e-06	0.000124	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAPK3—kidney cancer	6.48e-06	0.000123	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MYC—kidney cancer	6.3e-06	0.00012	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.29e-06	0.00012	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTP1—kidney cancer	6.23e-06	0.000119	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—MAPK1—kidney cancer	6.16e-06	0.000117	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ITPR2—kidney cancer	6.07e-06	0.000116	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PTEN—kidney cancer	5.94e-06	0.000113	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—KRAS—kidney cancer	5.82e-06	0.000111	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MAPK3—kidney cancer	5.76e-06	0.00011	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—GSTM1—kidney cancer	5.73e-06	0.000109	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—POMC—kidney cancer	5.71e-06	0.000109	CbGpPWpGaD
Betamethasone—PTGS2—Disease—RAF1—kidney cancer	5.62e-06	0.000107	CbGpPWpGaD
Betamethasone—NR3C1—Gene Expression—MYC—kidney cancer	5.6e-06	0.000107	CbGpPWpGaD
Betamethasone—PTGS2—Disease—ERBB2—kidney cancer	5.56e-06	0.000106	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTT1—kidney cancer	5.54e-06	0.000105	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ACHE—kidney cancer	5.54e-06	0.000105	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MTOR—kidney cancer	5.49e-06	0.000104	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CD4—kidney cancer	5.48e-06	0.000104	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—CYP1A1—kidney cancer	5.43e-06	0.000103	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—PIK3CA—kidney cancer	5.35e-06	0.000102	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SCARB1—kidney cancer	5.24e-06	9.98e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGS1—kidney cancer	5.19e-06	9.88e-05	CbGpPWpGaD
Betamethasone—PGR—Signaling Pathways—TP53—kidney cancer	5.17e-06	9.85e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CDKN1B—kidney cancer	5.15e-06	9.8e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PSMD7—kidney cancer	5.09e-06	9.69e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—CTNNB1—kidney cancer	4.87e-06	9.26e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—BCHE—kidney cancer	4.83e-06	9.19e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.77e-06	9.07e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PTEN—kidney cancer	4.74e-06	9.03e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.6e-06	8.76e-05	CbGpPWpGaD
Betamethasone—CYP19A1—Metabolism—PIK3CA—kidney cancer	4.19e-06	7.98e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAPK3—kidney cancer	4.05e-06	7.71e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—POMC—kidney cancer	4.05e-06	7.7e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PTEN—kidney cancer	3.97e-06	7.56e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MYC—kidney cancer	3.94e-06	7.5e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—MAPK1—kidney cancer	3.86e-06	7.34e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTP1—kidney cancer	3.84e-06	7.31e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—KRAS—kidney cancer	3.64e-06	6.93e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—ABCB1—kidney cancer	3.63e-06	6.92e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—GSTM1—kidney cancer	3.53e-06	6.72e-05	CbGpPWpGaD
Betamethasone—PTGS2—Disease—PIK3CA—kidney cancer	3.35e-06	6.37e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—CYP1A1—kidney cancer	3.35e-06	6.37e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTGS2—kidney cancer	3.23e-06	6.15e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PTEN—kidney cancer	2.82e-06	5.36e-05	CbGpPWpGaD
Betamethasone—PTGS2—Metabolism—PIK3CA—kidney cancer	2.8e-06	5.33e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—POMC—kidney cancer	2.49e-06	4.75e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTGS2—kidney cancer	1.99e-06	3.79e-05	CbGpPWpGaD
Betamethasone—ABCB1—Metabolism—PIK3CA—kidney cancer	1.99e-06	3.78e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PTEN—kidney cancer	1.73e-06	3.3e-05	CbGpPWpGaD
Betamethasone—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.22e-06	2.33e-05	CbGpPWpGaD
